What key tests occur following an AML diagnosis? Dr. Gail Roboz explains the procedures and tests to confirm the diagnosis, assess disease risk, examine AML genetic markers, and develop a treatment plan.
Dr. Gail Roboz is director of the Clinical and Translational Leukemia Programs and professor of medicine at Weill Cornell Medicine and the New York Presbyterian Hospital. Learn more about Dr. Roboz, here: weillcornell.org/gjroboz.
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to offer trusted information to empower anyone impacted by cancer, through health equity, health literacy and shared decision-making. Subscribe now to receive the latest news on cancer treatment and research: powerfulpatients.org/connect
13 июн 2024